Home › Shareholders OK Mylan's inversion deal with Abbott
 

Keywords :   


Shareholders OK Mylan's inversion deal with Abbott

2015-01-29 20:51:09| Biotech - Topix.net

Mylan Inc. shareholders voted Thursday to approve the company's pending acquisition of Abbott's non-U.S. developed markets specialty and branded generic business and reorganization in the Netherlands. Announced in July, the $5.3 billion all-stock transaction gives Abbott a 22 percent stake in Mylan and will move its generic business to a new company that will be headquartered in the tax-friendly Netherlands and called New Mylan.

Tags: deal shareholders abbott inversion

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11NI rise hits workers harder than employers, says OBR
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Wind Speed Probabilities Number 8
05.11Tropical Storm Rafael Public Advisory Number 8
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 8
05.11Lenzing Expands Nonwovens Range
05.11Netflix Europe offices raided in tax fraud probe
More »